Glioma cells often manipulate the necroptosis pathway to avert cell death, including the inhibition of RIPK1/RIPK3 activity and the prevention of downstream mixed lineage kinase domain-like protein (MLKL) translocation (94). This evidence concerns the gene MLKL and glioma.